James Cross

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi request reprint Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999
    James Cross
    Division of Metabolic and Endocrine Drug Products, Center for Drug Evaluation and Research, FDA, HFD 510, 5600 Fishers Lane, Rm 14 B 04, Rockville, MD 20857, USA
    Pharmacoepidemiol Drug Saf 11:439-46. 2002

Detail Information

Publications1

  1. ncbi request reprint Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999
    James Cross
    Division of Metabolic and Endocrine Drug Products, Center for Drug Evaluation and Research, FDA, HFD 510, 5600 Fishers Lane, Rm 14 B 04, Rockville, MD 20857, USA
    Pharmacoepidemiol Drug Saf 11:439-46. 2002
    ....